首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
US House biotech report
被引:0
|
作者
:
Jeffrey Fox
论文数:
0
引用数:
0
h-index:
0
Jeffrey Fox
机构
:
来源
:
Nature Biotechnology
|
2000年
/ 18卷
/ 6期
关键词
:
D O I
:
10.1038/76358
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:583 / 583
相关论文
共 50 条
[41]
US court bolsters biotech patent protection
Charlotte Harrison
论文数:
0
引用数:
0
h-index:
0
Charlotte Harrison
Nature Biotechnology,
2011,
29
: 672
-
673
[42]
Swiss firm Actelion to buy US biotech
不详
论文数:
0
引用数:
0
h-index:
0
不详
CHEMICAL & ENGINEERING NEWS,
2006,
84
(48)
: 17
-
17
[43]
US biotech prepares to fight generic biologics
Reid, B
论文数:
0
引用数:
0
h-index:
0
机构:
Alexandria, VA
Reid, B
NATURE BIOTECHNOLOGY,
2002,
20
(04)
: 322
-
322
[44]
US court bolsters biotech patent protection
Harrison, Charlotte
论文数:
0
引用数:
0
h-index:
0
Harrison, Charlotte
NATURE BIOTECHNOLOGY,
2011,
29
(08)
: 672
-
673
[45]
US company secures QLD biotech discovery
Dales, J
论文数:
0
引用数:
0
h-index:
0
机构:
QUT Fac Sci, FNC Project, Brisbane, Qld, Australia
QUT Fac Sci, FNC Project, Brisbane, Qld, Australia
Dales, J
AUSTRALASIAN BIOTECHNOLOGY,
2000,
10
(03)
: 13
-
13
[46]
China Biotech Scene, US Collaborations Grow
Caruso, Catherine
论文数:
0
引用数:
0
h-index:
0
Caruso, Catherine
CANCER DISCOVERY,
2020,
10
(03)
: 336
-
336
[47]
US biotech prepares to fight generic biologics
Brian Reid
论文数:
0
引用数:
0
h-index:
0
Brian Reid
Nature Biotechnology,
2002,
20
: 322
-
322
[48]
The importance of angels in starting a US biotech venture
Sohl, J
论文数:
0
引用数:
0
h-index:
0
机构:
Univ New Hampshire, Ctr Venture Res, Whittemore Sch Business & Econ, Durham, NH 03824 USA
Univ New Hampshire, Ctr Venture Res, Whittemore Sch Business & Econ, Durham, NH 03824 USA
Sohl, J
NATURE BIOTECHNOLOGY,
2005,
23
(02)
: 263
-
264
[49]
US and Japanese consumers are wary of biotech foods
Fairley, P
论文数:
0
引用数:
0
h-index:
0
Fairley, P
CHEMICAL WEEK,
1998,
160
(20)
: 46
-
46
[50]
US immigration order strikes against biotech
Jeremy M Levin
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Jeremy M Levin
Steven H Holtzman
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Steven H Holtzman
John Maraganore
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
John Maraganore
Paul J Hastings
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Paul J Hastings
Ron Cohen
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Ron Cohen
Bassil Dahiyat
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Bassil Dahiyat
Julian Adams
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Julian Adams
Chris Adams
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Chris Adams
Brett Ahrens
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Brett Ahrens
Jeff Albers
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Jeff Albers
Mara G Aspinall
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Mara G Aspinall
James E Audia
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
James E Audia
Martin Babler
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Martin Babler
Peter Barrett
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Peter Barrett
Zoe Barry
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Zoe Barry
Nessan Bermingham
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Nessan Bermingham
Stephen Bloch
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Stephen Bloch
Robert I Blum
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Robert I Blum
Paul B Bolno
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Paul B Bolno
Michael W Bonney
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Michael W Bonney
Bruce Booth
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Bruce Booth
Daniel M Bradbury
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Daniel M Bradbury
Steven K Brauer
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Steven K Brauer
Brook Byers
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Brook Byers
Pablo J Cagnoni
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Pablo J Cagnoni
Brian M Cali
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Brian M Cali
Isaac Ciechanover
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Isaac Ciechanover
Chip Clark
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Chip Clark
Michael D Clayman
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Michael D Clayman
Jeff L Cleland
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Jeff L Cleland
Paula Cobb
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Paula Cobb
Ron Cooper
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Ron Cooper
Mark G Currie
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Mark G Currie
John Diekman
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
John Diekman
Eric L Dobmeier
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Eric L Dobmeier
Doug Doerfler
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Doug Doerfler
Elizabeth LR Donley
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Elizabeth LR Donley
Deborah Dunsire
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Deborah Dunsire
Matthew During
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Matthew During
Jens W Eckstein
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Jens W Eckstein
Eric Elenko
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Eric Elenko
Neil A Exter
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Neil A Exter
Jonathan J Fleming
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Jonathan J Fleming
Gregory J Flesher
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Gregory J Flesher
Jean-Francois Formela
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Jean-Francois Formela
Robert Forrester
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Robert Forrester
Cedric Francois
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Cedric Francois
Heather Franklin
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Heather Franklin
Mason W Freeman
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Mason W Freeman
Howard Furst
论文数:
0
引用数:
0
h-index:
0
机构:
Ovid Therapeutics,
Howard Furst
Nature Biotechnology,
2017,
35
: 204
-
206
←
1
2
3
4
5
→